By Carl Foster, CBO, Standigm. AI has been a hot topic in the pharmaceutical industry, and the latest ChatGPT hype is fueling even more conversations. Right now, there’s a bifurcation of attitudes, with some scientists excited about the prospects of AI and others generally wary of it—which isn’t …